This paper from India, already 3 years old, is experimental but IMO could be on its way to supporting ATH434 in treating AD.Contrasting Effects of Ferric and Ferrous Ions on Oligomerization and Droplet Formation of Tau: Implications in Tauopathies and Neurodegeneration
AffiliationsDOI: 10.1021/acschemneuro.1c00377
- PMID: 34783530
Abstract
The dysregulation of metal homeostasis is reported to enhance the aggregation of tau, a key neuronal microtubule-associated protein. Herein, we found that ferric (Fe3+) ions enhanced tau aggregation. Fe3+ and Al3+ induced tau aggregation while several trivalent metal ions such as Cr3+, La3+, and V3+ had no discernable effect on tau aggregation. Fe3+ reduced the critical concentration of tau required for the liquid-liquid phase separation (LLPS); however, Cr3+, La3+, and V3+ did not affect tau droplet formation. Dynamic light scattering, atomic force microscopic, and transmission electron microscopic analysis suggested that Fe3+ significantly increased the formation of tau oligomers and fibrils. In contrast, Fe2+ neither enhanced tau droplet formation nor increased the heparin-induced aggregation of tau. Using a tryptophan mutant (Y310W-tau) of tau, Fe3+ was found to bind to tau with four times higher affinity than Fe2+. Acrylamide quenching of the tryptophan fluorescence of Y310W-tau, 1-anilino-8-naphthalene sulfonate (ANS) fluorescence experiment, and far-UV circular dichroism analysis indicated that Fe3+ decreased the solvent exposure of the tryptophan residue, perturbed the hydrophobic surface arrangement, and disrupted the secondary structure of tau, respectively. The increase in the β-sheet content and a subsequent decrease in the disordered content of tau due to the binding of Fe3+ may favor tau aggregation. Fe3+ may enhance and stabilize the non-covalent interactions between disordered domains of tau molecules leading to tau aggregation. The data highlighted the relationship between the dysregulation of ferric ions and neurodegenerative disorders.
Keywords:
- Forums
- ASX - By Stock
- Contrasting effects of Fe2+ and F3+ in Tau aggregation
ATH
alterity therapeutics limited
Add to My Watchlist
4.55%
!
1.1¢

This paper from India, already 3 years old, is experimental but...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.1¢ |
Change
-0.001(4.55%) |
Mkt cap ! $114.1M |
Open | High | Low | Value | Volume |
1.1¢ | 1.1¢ | 1.0¢ | $15.63K | 1.443M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
68 | 86049506 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 21641542 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
68 | 86049506 | 0.010 |
23 | 11789721 | 0.009 |
17 | 6649122 | 0.008 |
7 | 1792858 | 0.007 |
13 | 5304035 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 21641542 | 10 |
0.012 | 3683512 | 15 |
0.013 | 4992337 | 19 |
0.014 | 19347337 | 15 |
0.015 | 22294547 | 16 |
Last trade - 11.31am 19/09/2025 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |